Literature DB >> 28857035

Two common variants of human papillomavirus type 16 E6 differentially deregulate sugar metabolism and hypoxia signalling in permissive human keratinocytes.

Sean Cuninghame1, Robert Jackson1,2, Simon J Lees3,4, Ingeborg Zehbe4,1,3.   

Abstract

Human papillomavirus type 16 (HPV16) is responsible for most cancers attributable to HPV infection and naturally occurring variants of the HPV16 E6 oncoprotein predispose individuals to varying risk for developing cancer. Population studies by us and others have demonstrated that the common Asian-American E6 (AAE6) variant is a higher risk factor for cervical cancer than the E6 of another common variant, the European prototype (EPE6). However, a complete understanding of the molecular processes fundamental to these epidemiological findings is still lacking. Our previously published functional studies of these two E6 variants showed that AAE6 had a higher immortalization and transformation potential than EPE6. Proteomic analysis revealed markedly different protein patterns between these variants, especially with respect to key cellular metabolic enzymes. Here, we tested the Warburg effect and hypoxia signalling (hallmarks of cancer development) as plausible mechanisms underlying these observations. Lactate and glucose production were enhanced in AAE6-transduced keratinocytes, likely due to raised levels of metabolic enzymes, but independent of hypoxia-inducible factor 1 alpha (HIF-1α) activity. The HIF-1α protein level and activity were elevated by AAE6 in hypoxic conditions, leading to a hypoxia-tolerant phenotype with enhanced migratory potential. The deregulation of HIF-1α was caused by the AAE6 variant's ability to augment mitogen-activated protein kinase/extracellular related kinase signalling. The present study reveals prominent underlying mechanisms of the AAE6's enhanced oncogenic potential.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28857035     DOI: 10.1099/jgv.0.000905

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

Review 1.  Reprogramming of cellular metabolic pathways by human oncogenic viruses.

Authors:  John G Purdy; Micah A Luftig
Journal:  Curr Opin Virol       Date:  2019-11-22       Impact factor: 7.090

2.  An epithelial organoid model with Langerhans cells for assessing virus-host interactions.

Authors:  Robert Jackson; Statton Eade; Ingeborg Zehbe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

3.  Oncogenic Viruses as Entropic Drivers of Cancer Evolution.

Authors:  Italo Tempera; Paul M Lieberman
Journal:  Front Virol       Date:  2021-11-15

4.  The T350G Variation of Human Papillomavirus 16 E6 Gene Prevails in Oropharyngeal Cancer from a Small Cohort of Greek Patients.

Authors:  Christine Kottaridi; Panagiota Resta; Danai Leventakou; Katerina Gioti; Ioannis Zygouras; Alina-Roxani Gouloumi; Georgios Sakagiannis; Khalid J Alzahrani; Maria S Venetikou; Fragkiski Anthouli-Anagnostopoulou; Apostolos Beloukas
Journal:  Viruses       Date:  2022-08-04       Impact factor: 5.818

5.  Deep Sequencing of HPV16 E6 Region Reveals Unique Mutation Pattern of HPV16 and Predicts Cervical Cancer.

Authors:  Wenchao Ai; Chuanyong Wu; Liqing Jia; Xiao Xiao; Xuewen Xu; Min Ren; Tian Xue; Xiaoyan Zhou; Ying Wang; Chunfang Gao
Journal:  Microbiol Spectr       Date:  2022-06-23

6.  Virus-Host Protein-Protein Interactions between Human Papillomavirus 16 E6 A1 and D2/D3 Sub-Lineages: Variances and Similarities.

Authors:  Guillem Dayer; Mehran L Masoom; Melissa Togtema; Ingeborg Zehbe
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

Review 7.  Metabolic Reprogramming in Cancer: Role of HPV 16 Variants.

Authors:  Adán Arizmendi-Izazaga; Napoleón Navarro-Tito; Hilda Jiménez-Wences; Miguel A Mendoza-Catalán; Dinorah N Martínez-Carrillo; Ana E Zacapala-Gómez; Monserrat Olea-Flores; Roberto Dircio-Maldonado; Francisco I Torres-Rojas; Diana G Soto-Flores; Berenice Illades-Aguiar; Julio Ortiz-Ortiz
Journal:  Pathogens       Date:  2021-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.